Affiliation:
1. Department of Clinical Pharmacology, PLA General Hospital, Beijing 100853, People's Republic of China
Abstract
ABSTRACT
The antimicrobial activities of colistin and other antibiotics against clinical
Acinetobacter baumannii
and the mutant prevention concentration (MPC) of colistin against multidrug-resistant
A. baumannii
were studied. All 70 stains tested were sensitive to colistin. The MPC range of colistin against 30 multidrug-resistant
A. baumannii
stains was approximately 32 to >128 μg/ml, and the MPC at which 90% of the isolates tested were prevented (MPC
90
) exceeded 128 μg/ml, which was much higher than the plasma concentration of colistin at the current recommended dosage. So, combination therapy for colistin treatment of
A. baumannii
would be prudent to slow the emergence of resistance.
Publisher
American Society for Microbiology
Subject
Infectious Diseases,Pharmacology (medical),Pharmacology
Cited by
29 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献